Bridge to Life: Series C+DebtMakes organ preservation and perfusion technology for liver transplantsOct 4, 2026RoundOSBridge to LifeCompany profile and funding historySourcesprnewswire.comMore in HealthtechMetriport · Series AProFound Therapeutics · StrategicArintra · Series BUnited StatesHealthtechNorth AmericaUndisclosed